Compare $CV vs $NPCE | Chartloom

Compare

$CV vs $NPCE

CapsoVision Inc · Neuropace Inc

CapsoVision Inc

NPCE

Neuropace Inc

Compare $CV vs $NPCE

Comparing CapsoVision Inc and Neuropace Inc

CVCapsoVision Inc

NPCENeuropace Inc

CVCapsoVision Inc

Market cap

$329M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

18.89x

Rev growth (TTM)

-31.7%

YTD performance

-35.6%

52W performance

43.3%

FCF yield

-8.5%

NPCENeuropace Inc

Market cap

$432M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.83x

Rev growth (TTM)

11.6%

YTD performance

-16.5%

52W performance

13.8%

FCF yield

-2.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NPCE

Detailed metrics comparison

CapsoVision Inc

NPCE

Neuropace Inc

Market Cap

CV$329M

NPCE$432M

Enterprise Value

CV$320M

NPCE$478M

Price

CV$6.59

NPCE$12.67

P/E Ratio

CVN/A

NPCEN/A

P/S Ratio

CV23.70x

NPCE4.37x

EV/Sales

CV23.05x

NPCE4.84x

EV/EBITDA

CV0.00x

NPCE0.00x

P/B Ratio

CV24.94x

NPCE36.68x

P/FCF Ratio

CVN/A

NPCEN/A

EV/FCF

CV-11.48x

NPCE-41.21x

PEG Ratio

CVN/A

NPCEN/A

Forward P/E (NTM)

CVN/A

NPCEN/A

Forward P/S (NTM)

CV18.89x

NPCE3.83x

Revenue (TTM)

CV$14M

NPCE$99M

Revenue Growth (YoY)

CV-31.7%

NPCE11.6%

Forward Rev Growth

CV33.3%

NPCE22.0%

Gross Margin (TTM)

CV50.9%

NPCE79.6%

Operating Margin (TTM)

CV0.0%

NPCE0.0%

EBITDA Margin (TTM)

CV-215.5%

NPCE-15.0%

Net Margin (TTM)

CV-214.7%

NPCE-19.3%

FCF Margin (TTM)

CV-200.8%

NPCE-11.7%

Net Income (TTM)

CV$-30M

NPCE$-19M

FCF (TTM)

CV$-28M

NPCE$-12M

EPS (TTM)

CV-$0.60

NPCE-$0.56

ROE (TTM)

CV-17785.0%

NPCE-11968.0%

ROA (TTM)

CV-13507.0%

NPCE-1871.0%

ROIC (TTM)

CV-17785.0%

NPCE-2552.0%

Cash

CV$9M

NPCE$13M

Debt

CV$0

NPCE$59M

Net Cash/Debt

CV$9M

NPCE$-46M

Current Ratio (TTM)

CV3.35x

NPCE4.94x

Quick Ratio (TTM)

CV2.31x

NPCE3.82x

Debt/Equity (TTM)

CV0.00x

NPCE4.97x

Debt/Assets (TTM)

CV0.0%

NPCE0.0%

Interest Coverage (TTM)

CVN/A

NPCEN/A

Net Debt/EBITDA (TTM)

CV0.00x

NPCE0.00x

Beta

CV-1.80

NPCE1.95

52W Performance

CV43.3%

NPCE13.8%

YTD Performance

CV-35.6%

NPCE-16.5%

% from 52W High

CV-57.1%

NPCE-35.4%

% from 52W Low

CV50.5%

NPCE37.4%

Asset Turnover (TTM)

CV0.63x

NPCE0.97x

FCF Yield (TTM)

CV-8.5%

NPCE-2.7%

Earnings Yield (TTM)

CV-9.1%

NPCE-4.4%

Dividend Yield (TTM)

CVN/A

NPCEN/A

Rule of 40

CV-232.5

NPCE-0.2

EV/GP/RG

CV1.78

NPCE0.40

Ticker research

View CV research View NPCE research

Metric	CV CapsoVision Inc	NPCE Neuropace Inc
Market & Valuation
Market Cap	$329M	$432M
Enterprise Value	$320M	$478M
Price	$6.59	$12.67
P/E Ratio	N/A	N/A
P/S Ratio	23.70x	4.37x
EV/Sales	23.05x	4.84x
EV/EBITDA	0.00x	0.00x
P/B Ratio	24.94x	36.68x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.48x	-41.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	18.89x	3.83x
Revenue & Growth
Revenue (TTM)	$14M	$99M
Revenue Growth (YoY)	-31.7%	11.6%
Forward Rev Growth	33.3%	22.0%
Profitability
Gross Margin (TTM)	50.9%	79.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-215.5%	-15.0%
Net Margin (TTM)	-214.7%	-19.3%
FCF Margin (TTM)	-200.8%	-11.7%
Net Income (TTM)	$-30M	$-19M
FCF (TTM)	$-28M	$-12M
EPS (TTM)	-$0.60	-$0.56
ROE (TTM)	-17785.0%	-11968.0%
ROA (TTM)	-13507.0%	-1871.0%
ROIC (TTM)	-17785.0%	-2552.0%
Financial Health
Cash	$9M	$13M
Debt	$0	$59M
Net Cash/Debt	$9M	$-46M
Current Ratio (TTM)	3.35x	4.94x
Quick Ratio (TTM)	2.31x	3.82x
Debt/Equity (TTM)	0.00x	4.97x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.80	1.95
52W Performance	43.3%	13.8%
YTD Performance	-35.6%	-16.5%
% from 52W High	-57.1%	-35.4%
% from 52W Low	50.5%	37.4%
Efficiency & Yields
Asset Turnover (TTM)	0.63x	0.97x
FCF Yield (TTM)	-8.5%	-2.7%
Earnings Yield (TTM)	-9.1%	-4.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-232.5	-0.2
EV/GP/RG	1.78	0.40
Ticker research	View CV research	View NPCE research

Valuation

P/S Ratio

NPCE

4.37x

23.70x

EV/FCF

NPCE

-41.21x

-11.48x

Growth & revenue

Revenue Growth TTM

NPCE

11.6%

-31.7%

Forward Revenue Growth

33.3%

NPCE

22.0%

Profitability & performance

Gross Margin

NPCE

79.6%

50.9%

ROE

NPCE

-11968.0%

-17785.0%

FCF Yield %

NPCE

-2.7%

-8.5%

52-Week Performance

43.3%

NPCE

13.8%

Detailed metrics comparison

CapsoVision Inc

NPCE

Neuropace Inc

Market Cap

CV$329M

NPCE$432M

Enterprise Value

CV$320M

NPCE$478M

Price

CV$6.59

NPCE$12.67

P/E Ratio

CVN/A

NPCEN/A

P/S Ratio

CV23.70x

NPCE4.37x

EV/Sales

CV23.05x

NPCE4.84x

EV/EBITDA

CV0.00x

NPCE0.00x

P/B Ratio

CV24.94x

NPCE36.68x

P/FCF Ratio

CVN/A

NPCEN/A

EV/FCF

CV-11.48x

NPCE-41.21x

PEG Ratio

CVN/A

NPCEN/A

Forward P/E (NTM)

CVN/A

NPCEN/A

Forward P/S (NTM)

CV18.89x

NPCE3.83x

Revenue (TTM)

CV$14M

NPCE$99M

Revenue Growth (YoY)

CV-31.7%

NPCE11.6%

Forward Rev Growth

CV33.3%

NPCE22.0%

Gross Margin (TTM)

CV50.9%

NPCE79.6%

Operating Margin (TTM)

CV0.0%

NPCE0.0%

EBITDA Margin (TTM)

CV-215.5%

NPCE-15.0%

Net Margin (TTM)

CV-214.7%

NPCE-19.3%

FCF Margin (TTM)

CV-200.8%

NPCE-11.7%

Net Income (TTM)

CV$-30M

NPCE$-19M

FCF (TTM)

CV$-28M

NPCE$-12M

EPS (TTM)

CV-$0.60

NPCE-$0.56

ROE (TTM)

CV-17785.0%

NPCE-11968.0%

ROA (TTM)

CV-13507.0%

NPCE-1871.0%

ROIC (TTM)

CV-17785.0%

NPCE-2552.0%

Cash

CV$9M

NPCE$13M

Debt

CV$0

NPCE$59M

Net Cash/Debt

CV$9M

NPCE$-46M

Current Ratio (TTM)

CV3.35x

NPCE4.94x

Quick Ratio (TTM)

CV2.31x

NPCE3.82x

Debt/Equity (TTM)

CV0.00x

NPCE4.97x

Debt/Assets (TTM)

CV0.0%

NPCE0.0%

Interest Coverage (TTM)

CVN/A

NPCEN/A

Net Debt/EBITDA (TTM)

CV0.00x

NPCE0.00x

Beta

CV-1.80

NPCE1.95

52W Performance

CV43.3%

NPCE13.8%

YTD Performance

CV-35.6%

NPCE-16.5%

% from 52W High

CV-57.1%

NPCE-35.4%

% from 52W Low

CV50.5%

NPCE37.4%

Asset Turnover (TTM)

CV0.63x

NPCE0.97x

FCF Yield (TTM)

CV-8.5%

NPCE-2.7%

Earnings Yield (TTM)

CV-9.1%

NPCE-4.4%

Dividend Yield (TTM)

CVN/A

NPCEN/A

Rule of 40

CV-232.5

NPCE-0.2

EV/GP/RG

CV1.78

NPCE0.40

Ticker research

View CV research View NPCE research

Metric	CV CapsoVision Inc	NPCE Neuropace Inc
Market & Valuation
Market Cap	$329M	$432M
Enterprise Value	$320M	$478M
Price	$6.59	$12.67
P/E Ratio	N/A	N/A
P/S Ratio	23.70x	4.37x
EV/Sales	23.05x	4.84x
EV/EBITDA	0.00x	0.00x
P/B Ratio	24.94x	36.68x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.48x	-41.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	18.89x	3.83x
Revenue & Growth
Revenue (TTM)	$14M	$99M
Revenue Growth (YoY)	-31.7%	11.6%
Forward Rev Growth	33.3%	22.0%
Profitability
Gross Margin (TTM)	50.9%	79.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-215.5%	-15.0%
Net Margin (TTM)	-214.7%	-19.3%
FCF Margin (TTM)	-200.8%	-11.7%
Net Income (TTM)	$-30M	$-19M
FCF (TTM)	$-28M	$-12M
EPS (TTM)	-$0.60	-$0.56
ROE (TTM)	-17785.0%	-11968.0%
ROA (TTM)	-13507.0%	-1871.0%
ROIC (TTM)	-17785.0%	-2552.0%
Financial Health
Cash	$9M	$13M
Debt	$0	$59M
Net Cash/Debt	$9M	$-46M
Current Ratio (TTM)	3.35x	4.94x
Quick Ratio (TTM)	2.31x	3.82x
Debt/Equity (TTM)	0.00x	4.97x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.80	1.95
52W Performance	43.3%	13.8%
YTD Performance	-35.6%	-16.5%
% from 52W High	-57.1%	-35.4%
% from 52W Low	50.5%	37.4%
Efficiency & Yields
Asset Turnover (TTM)	0.63x	0.97x
FCF Yield (TTM)	-8.5%	-2.7%
Earnings Yield (TTM)	-9.1%	-4.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-232.5	-0.2
EV/GP/RG	1.78	0.40
Ticker research	View CV research	View NPCE research